| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_015f07f1629a11bc8437f52f7bf1f076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1abdf91a07d6db414fa755a0d05b0ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_162e2a25357baf7066ade97085633f65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_056d31e894cb52a73ed3ec7e8979dcdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e359dd414a23fb1171939ea4a9d7f5e4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 |
| filingDate |
2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a9db545311ddfe99e136ce2a843f84b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a3208535c6f50a5fb4e99ae176a72c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc53efb0c3d6f710adbe86e79bff2df4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75e49678b552fba85cfabf542b589781 |
| publicationDate |
2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8546344-B2 |
| titleOfInvention |
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole |
| abstract |
The invention relates to novel crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-(β-L-ribofuranosyl)-1H-benzimidazole (Maribavir), pharmaceutical compositions thereof and their use in medical therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130777-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765692-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684632-B2 |
| priorityDate |
2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |